nivolumab combined with ibrutinib for cll, richter transformation
Published 7 years ago • 170 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:18
an overview of a study combining nivolumab with ibrutinib in cll and richter transformation
-
1:54
nivolumab ibrutinib for patients with richter’s transformation
-
2:08
phase ii trial of nivolumab combined with ibrutinib for patients with richter transformation
-
1:09
results for the combination of nivolumab and ibrutinib in non-hodgkin lymphoma and cll
-
1:15
the combination of copanlisib and nivolumab in patient's with richter's transformation
-
2:14
richter’s syndrome in patients with cll on novel therapy
-
1:26
phase i trial of copanlisib nivolumab in patients with richter’s transformation or transformed fl
-
1:46
acalabrutinib for the treatment of richter's transformation and patients with ibrutinib intolerance
-
1:14
dr. zelenetz on nivolumab plus ibrutinib in patients with cll
-
1:05
evaluating copanlisib in combination with nivolumab in patients with rt or transformed nhl
-
1:37
u2' regimen with checkpoint inhibition in r/r cll and richter's transformation
-
7:03
case 3: progression on ibrutinib followed by richter transformation
-
1:35
chemotherapy-free induction with ibrutinib-rituximab
-
4:08
phase ib trial of ianalumab plus ibrutinib for cll
-
2:46
a phase ii trial of pembrolizumab for richter's transformation of cll
-
2:38
ibrutinib treatment for cll does not increase the incidence of richter’s transformation
-
1:09:01
dr nicholas martinez discusses richter's transformation
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
1:02
dr. hellmann on nivolumab in combination with ipilimumab for small cell lung cancer